vs
Side-by-side financial comparison of Civeo Corp (CVEO) and OPKO HEALTH, INC. (OPK). Click either name above to swap in a different company.
Civeo Corp is the larger business by last-quarter revenue ($161.6M vs $148.5M, roughly 1.1× OPKO HEALTH, INC.). Civeo Corp runs the higher net margin — -4.0% vs -21.1%, a 17.1% gap on every dollar of revenue. On growth, Civeo Corp posted the faster year-over-year revenue change (7.1% vs -19.2%). Civeo Corp produced more free cash flow last quarter ($14.5M vs $-28.6M). Over the past eight quarters, Civeo Corp's revenue compounded faster (-1.4% CAGR vs -7.5%).
The Civeo Corporation is an American accommodation services multinational corporation. It is a spin-off of Oil States International. It is a public company listed on the New York Stock Exchange.
OPKO Health, Inc. is a medical test and medication company focused on diagnostics and pharmaceuticals. The company is a publicly traded company on NASDAQ and TASE under the symbol "OPK".
CVEO vs OPK — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | ||
|---|---|---|
| Revenue | $161.6M | $148.5M |
| Net Profit | $-6.5M | $-31.3M |
| Gross Margin | 22.7% | 43.1% |
| Operating Margin | -0.1% | -25.8% |
| Net Margin | -4.0% | -21.1% |
| Revenue YoY | 7.1% | -19.2% |
| Net Profit YoY | 58.1% | -322.8% |
| EPS (diluted) | $-0.58 | $-0.04 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $161.6M | $148.5M | ||
| Q3 25 | $170.5M | $151.7M | ||
| Q2 25 | $162.7M | $156.8M | ||
| Q1 25 | $144.0M | $150.0M | ||
| Q4 24 | $151.0M | $183.6M | ||
| Q3 24 | $176.3M | $173.6M | ||
| Q2 24 | $188.7M | $182.2M | ||
| Q1 24 | $166.1M | $173.7M |
| Q4 25 | $-6.5M | $-31.3M | ||
| Q3 25 | $-455.0K | $21.6M | ||
| Q2 25 | $-3.3M | $-148.4M | ||
| Q1 25 | $-9.8M | $-67.6M | ||
| Q4 24 | $-15.4M | $14.0M | ||
| Q3 24 | $-5.1M | $24.9M | ||
| Q2 24 | $8.2M | $-10.3M | ||
| Q1 24 | $-5.1M | $-81.8M |
| Q4 25 | 22.7% | 43.1% | ||
| Q3 25 | 25.7% | 32.9% | ||
| Q2 25 | 25.3% | 31.5% | ||
| Q1 25 | 20.4% | 28.4% | ||
| Q4 24 | 18.6% | 46.1% | ||
| Q3 24 | 21.4% | 23.1% | ||
| Q2 24 | 25.4% | 28.4% | ||
| Q1 24 | 21.5% | 24.2% |
| Q4 25 | -0.1% | -25.8% | ||
| Q3 25 | 4.1% | 31.7% | ||
| Q2 25 | 1.7% | -38.3% | ||
| Q1 25 | -3.8% | -44.8% | ||
| Q4 24 | -6.7% | -18.0% | ||
| Q3 24 | 0.0% | 8.2% | ||
| Q2 24 | 6.9% | -33.9% | ||
| Q1 24 | -1.1% | -41.2% |
| Q4 25 | -4.0% | -21.1% | ||
| Q3 25 | -0.3% | 14.3% | ||
| Q2 25 | -2.0% | -94.7% | ||
| Q1 25 | -6.8% | -45.1% | ||
| Q4 24 | -10.2% | 7.6% | ||
| Q3 24 | -2.9% | 14.3% | ||
| Q2 24 | 4.4% | -5.7% | ||
| Q1 24 | -3.1% | -47.1% |
| Q4 25 | $-0.58 | $-0.04 | ||
| Q3 25 | $-0.04 | $0.03 | ||
| Q2 25 | $-0.25 | $-0.19 | ||
| Q1 25 | $-0.72 | $-0.10 | ||
| Q4 24 | $-1.04 | $0.02 | ||
| Q3 24 | $-0.36 | $0.03 | ||
| Q2 24 | $0.56 | $-0.01 | ||
| Q1 24 | $-0.35 | $-0.12 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | ||
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $14.4M | $364.4M |
| Total DebtLower is stronger | — | $344.0M |
| Stockholders' EquityBook value | $174.4M | $1.3B |
| Total Assets | $477.4M | $1.9B |
| Debt / EquityLower = less leverage | — | 0.27× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $14.4M | $364.4M | ||
| Q3 25 | $12.0M | $412.0M | ||
| Q2 25 | $14.6M | $267.3M | ||
| Q1 25 | $28.4M | $428.8M | ||
| Q4 24 | $5.2M | $426.6M | ||
| Q3 24 | $17.9M | $400.1M | ||
| Q2 24 | $7.4M | $40.6M | ||
| Q1 24 | $16.8M | $75.6M |
| Q4 25 | — | $344.0M | ||
| Q3 25 | — | $344.2M | ||
| Q2 25 | — | $343.3M | ||
| Q1 25 | — | $439.2M | ||
| Q4 24 | $43.3M | $437.2M | ||
| Q3 24 | — | $441.0M | ||
| Q2 24 | — | $201.9M | ||
| Q1 24 | — | $350.1M |
| Q4 25 | $174.4M | $1.3B | ||
| Q3 25 | $182.5M | $1.3B | ||
| Q2 25 | $209.4M | $1.3B | ||
| Q1 25 | $220.7M | $1.3B | ||
| Q4 24 | $236.4M | $1.4B | ||
| Q3 24 | $282.2M | $1.4B | ||
| Q2 24 | $297.4M | $1.4B | ||
| Q1 24 | $297.4M | $1.3B |
| Q4 25 | $477.4M | $1.9B | ||
| Q3 25 | $491.1M | $2.0B | ||
| Q2 25 | $508.8M | $2.0B | ||
| Q1 25 | $423.8M | $2.1B | ||
| Q4 24 | $405.1M | $2.2B | ||
| Q3 24 | $477.6M | $2.3B | ||
| Q2 24 | $483.2M | $2.0B | ||
| Q1 24 | $513.1M | $2.0B |
| Q4 25 | — | 0.27× | ||
| Q3 25 | — | 0.26× | ||
| Q2 25 | — | 0.26× | ||
| Q1 25 | — | 0.33× | ||
| Q4 24 | 0.18× | 0.32× | ||
| Q3 24 | — | 0.31× | ||
| Q2 24 | — | 0.14× | ||
| Q1 24 | — | 0.28× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | ||
|---|---|---|
| Operating Cash FlowLast quarter | $19.3M | $-25.9M |
| Free Cash FlowOCF − Capex | $14.5M | $-28.6M |
| FCF MarginFCF / Revenue | 8.9% | -19.3% |
| Capex IntensityCapex / Revenue | 3.0% | 1.8% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $2.1M | $-190.8M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $19.3M | $-25.9M | ||
| Q3 25 | $13.8M | $-34.6M | ||
| Q2 25 | $-2.3M | $-83.4M | ||
| Q1 25 | $-8.4M | $-34.6M | ||
| Q4 24 | $9.5M | $-44.4M | ||
| Q3 24 | $35.7M | $-77.1M | ||
| Q2 24 | $32.4M | $-26.4M | ||
| Q1 24 | $6.0M | $-35.6M |
| Q4 25 | $14.5M | $-28.6M | ||
| Q3 25 | $8.2M | $-37.8M | ||
| Q2 25 | $-6.8M | $-86.7M | ||
| Q1 25 | $-13.7M | $-37.7M | ||
| Q4 24 | $1.8M | $-49.8M | ||
| Q3 24 | $28.2M | $-85.0M | ||
| Q2 24 | $27.0M | $-33.7M | ||
| Q1 24 | $372.0K | $-40.0M |
| Q4 25 | 8.9% | -19.3% | ||
| Q3 25 | 4.8% | -24.9% | ||
| Q2 25 | -4.2% | -55.3% | ||
| Q1 25 | -9.5% | -25.2% | ||
| Q4 24 | 1.2% | -27.1% | ||
| Q3 24 | 16.0% | -49.0% | ||
| Q2 24 | 14.3% | -18.5% | ||
| Q1 24 | 0.2% | -23.0% |
| Q4 25 | 3.0% | 1.8% | ||
| Q3 25 | 3.3% | 2.1% | ||
| Q2 25 | 2.8% | 2.1% | ||
| Q1 25 | 3.7% | 2.1% | ||
| Q4 24 | 5.1% | 2.9% | ||
| Q3 24 | 4.2% | 4.6% | ||
| Q2 24 | 2.8% | 4.0% | ||
| Q1 24 | 3.4% | 2.6% |
| Q4 25 | — | — | ||
| Q3 25 | — | -1.60× | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | -3.17× | ||
| Q3 24 | — | -3.10× | ||
| Q2 24 | 3.93× | — | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
CVEO
Segment breakdown not available.
OPK
| Services | $71.1M | 48% |
| Transfer Of Intellectual Property And Other | $33.7M | 23% |
| IE | $22.1M | 15% |
| Rayaldee | $8.8M | 6% |
| Barda Agreement | $6.8M | 5% |
| MX | $6.3M | 4% |